Floatz logo

POLO-LIKE KINASE 1 INHIBITOR NMS-1286937

Inflammatory Breast Cancer

Antonio Giordano, MDSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

25 Active assets in the Inflammatory Breast Cancer cohort.

Asset / SponsorPhaseRating
Carboplatin
Northwestern University
Phase 3BBB
TRASTUZUMAB
Hoffmann-La Roche
Phase 3BBB
Cyclophosphamide
Northwestern University
Phase 3BBB
Docetaxel
Association Tunisienne de lutte Contre le Cancer
Phase 3BBB
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Hoffmann-La Roche
Phase 3BBB

View all 50 →

Same molecule, other indications

POLO-LIKE KINASE 1 INHIBITOR NMS-1286937 is also rated in:

pancreatic ductal adenocarcinomaDormant
B
Indicative ·
60 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
58 / 100
View asset →
malignant pancreatic neoplasmDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →